Yahoo Poland Wyszukiwanie w Internecie

Search results

1. fusionpharma.comThe Evolution of Radiopharmaceuticals - Fusion Pharma - Home

   fusionpharma.com

   • Zapisane w pamięci cache

   We created a proprietary linker to connect cancer-seeking molecules and alpha emitting medical isotopes. The Fast-Clear™ linker was specifically engineered to improve the safety of radiopharmaceuticals by helping the drug clear from normal, healthy tissues.

   • About

     At Fusion, we are pushing the boundaries of science to...

   • Pipeline

     Fusion’s lead program, FPI-2265, is evaluating 225 Ac-PSMA...

   • Technology

     Given the power and versatility of the Fast-Clear™ linker...

   • Careers

     Fusion Management. The faces behind Fusion Pharmaceuticals....

   • Fusion Leadership

     Before joining Fusion, he was Vice President of Development...

   • Advisory Board

     Dr. Khuntia is a board-certified radiation oncologist who...

   • Contact

     CONTACT FUSION. Get in touch. info@fusionpharma.com Toll...

   • Expanded Access Policy

     Fusion reserves the right to revise this expanded access...

2. www.astrazeneca.com › media-centre › press-releasesAcquisition of Fusion completed - AstraZeneca

   www.astrazeneca.com › media-centre › press-releases

   • Zapisane w pamięci cache

   4 cze 2024 · AstraZeneca today announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

3. www.astrazeneca.com › press-releases › 2024AstraZeneca to acquire Fusion to accelerate the development of...

   www.astrazeneca.com › press-releases › 2024

   • Zapisane w pamięci cache

   19 mar 2024 · AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

4. finance.yahoo.com › news › fusion-pharmaceuticals-acquired-astrazenecaFusion Pharmaceuticals to be Acquired by AstraZeneca,...

   finance.yahoo.com › news › fusion-pharmaceuticals-acquired-astrazeneca

   • Zapisane w pamięci cache

   19 mar 2024 · Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced the Company has...

5. www.prnewswire.com › news-releases › fusion-pharmaceuticals-to-be-acquired-by-astFusion Pharmaceuticals to be Acquired by AstraZeneca,...

   www.prnewswire.com › news-releases › fusion-pharmaceuticals-to-be-acquired-by-ast

   • Zapisane w pamięci cache

   19 mar 2024 · Transaction includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities.

6. fusionpharma.com › aboutThe future of radiation therapy - Fusion Pharma - About

   fusionpharma.com › about

   • Zapisane w pamięci cache

   At Fusion, we are pushing the boundaries of science to create innovative precision medicines for cancer. We are a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer.

7. www.prnewswire.com › news-releases › acquisition-of-fusion-pharmaceuticalsAcquisition of Fusion Pharmaceuticals Completed - PR Newswire

   www.prnewswire.com › news-releases › acquisition-of-fusion-pharmaceuticals

   • Zapisane w pamięci cache

   4 cze 2024 · Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation RCs. Fusion connects alpha particle emitting isotopes to various targeting molecules in...